**Acknowledgements**

We thank Dr. Frank Esper (Department of Infectious Disease, Cleveland Clinic Children's) for his insightful comments regarding an earlier version of this chapter. This work was supported by a NIH K08 AI112781 (F.R.) grant.

**71**

**Author details**

Debra T. Linfield1

Cleveland, OH, USA

OH, USA

provided the original work is properly cited.

Clinic Foundation, Cleveland, OH, USA

\*Address all correspondence to: rezaeef@ccf.org

and Fariba Rezaee2,3\*

*RSV: Available Prophylactic Options and Vaccines in Clinical Trials*

*DOI: http://dx.doi.org/10.5772/intechopen.84851*

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium,

1 Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

2 Center for Pediatric Pulmonary Medicine, Cleveland Clinic Children's, Cleveland,

3 Department of Inflammation and Immunity, Lerner Research Institute Cleveland
